Pathological manifestation of the induced pluripotent stem cell-derived contical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation(S170F).

A preparing method of astrocytes and drug screening method using thereof. (1020250201048)

Composition for preventing and treating stroke, comprising HLA homozygous induced pluripotent stem cell-derived neural precursor cells. (18/564,485)

Composition for screening treatment of early-onset Alzheimer's disease and method there of. (102442670)

Composition for preventing and treating stroke, comprising HLA homozygous induced pluripotent stem cell-derived neural precursor cells.

Huntington's disease cell model and Huntington's disease screening model using the same. (1020220002787)

Composition of preventing and treating the stroke comprising HLA-homozygous iPSC-derived neural precursor cells. (102329306)

Huntington's disease treatment or prevention composition comprising human leukocyte antigen homozygous pluripotent stem cell-derived neural precursor cells. (102329305)

Induced pluripotent stem cells having presenilin protein mutants (E120K) derived from Alzheimer's disease patients. (102203860)

Induced pluripotent stem cells having amyloid precursor protein mutants (v715m) derived from Alzheimer's disease patients. (102203861)

Induced pluripotent stem cells of Alzheimer's disease patient with mutation (V715M) in amyloid precursor protein.